Practice Short cuts

Metformin remains the logical first line drug for type 2 diabetes

BMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.333.7581.1265-c (Published 14 December 2006) Cite this as: BMJ 2006;333:1265

In people with type 2 diabetes, the relatively new drug rosiglitazone was significantly better at lowering blood glucose than metformin or glyburide. But at least one independent expert says metformin should remain the recommended first line treatment (pp 2477-80). Why?

Rosiglitazone significantly …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe